Evidence map›Paper›PMID 35368611›Full record

ArticleRevista espanola de medicina nuclear e imagen molecular

[

B Rodríguez-Alfonso, S Ruiz Solís, L Silva-Hernández, I Pintos Pascual, S Aguado Ibáñez, C Salas Antón

Open access · greenAbstract read
In one paragraph

Article in Revista espanola de medicina nuclear e imagen molecular. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

B Rodríguez-AlfonsoServicio de Medicina Nuclear del Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, España.
S Ruiz SolísServicio de Medicina Nuclear del Hospital Universitario 12 de Octubre, Madrid, España.
L Silva-HernándezServicio de Neurología del Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, España.
I Pintos PascualServicio de Medicina Interna del Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, España.
S Aguado IbáñezServicio de Neumología del Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, España.
C Salas AntónServicio de Anatomía Patológica del Hospital Universitario Puerta de Hierro, Majadahonda, Madrid, España.
Hospital Universitario Puerta de Hierro Majadahonda · ESHospital Universitario 12 De Octubre · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent months, much of the scientific efforts have focused on research on SARSCoV-2 infection and its consequences in humans. Still, many aspects remain unknown. It is known that the damage caused by SARS-CoV-2 is multifactorial and that its extension goes beyond lung inflammation and the acute phase, with the appearance of numerous complications and sequelae. To date, knowledge about the usefulness of

Indexed as

COVID-19Fluorodeoxyglucose F18HumansPositron Emission Tomography Computed TomographyPost-Acute COVID-19 SyndromeRadiopharmaceuticalsSARS-CoV-2Fluorodeoxyglucose F18Radiopharmaceuticals18F-FDG-PET/CTInflammationLong COVID-19SARS-CoV-2Vaccine

Identifiers

PMID35368611
PMCPMC8272978
OpenAlexW3177521668

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.